KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 103 filers reported holding KEROS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $352,379 | -79.0% | 8,770 | -77.7% | 0.00% | – |
| Q1 2023 | $1,676,103 | +140.6% | 39,253 | +170.6% | 0.00% | – |
| Q4 2022 | $696,626 | -59.2% | 14,507 | -68.1% | 0.00% | – |
| Q3 2022 | $1,709,000 | -6.9% | 45,422 | +34.6% | 0.00% | – |
| Q1 2022 | $1,835,000 | -72.0% | 33,745 | -69.8% | 0.00% | – |
| Q4 2021 | $6,544,000 | +1178.1% | 111,866 | +763.6% | 0.00% | – |
| Q3 2021 | $512,000 | +38.4% | 12,953 | +48.5% | 0.00% | – |
| Q2 2021 | $370,000 | -59.0% | 8,723 | -31.8% | 0.00% | – |
| Q4 2020 | $902,000 | – | 12,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |